Measurement of public health impacts of cannabis legalization in Canada to reflect policy maker priorities: A rapid scoping review of instruments and content domains.
Autor: | Lazor T; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, M5T 3M6 Toronto, Canada. Electronic address: tanya.hesser@alum.utoronto.ca., Blondal E; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, M5T 3M6 Toronto, Canada. Electronic address: erik.blondal@alum.utoronto.ca., Scheim A; Centre on Drug Policy Evaluation, St. Michael's Hospital, M5B 1W8 Toronto, Canada; Department of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, 19104 Philadelphia, USA. Electronic address: ais63@drexel.edu., Cubillos P; Clinica Las Americas, Medellín, Colombia. Electronic address: paola@drpaola.ca., Werb D; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, M5T 3M6 Toronto, Canada; Centre on Drug Policy Evaluation, St. Michael's Hospital, M5B 1W8 Toronto, Canada; Division of Infectious Diseases and Global Public Health, University of California San Diego, 92093 CA, USA. Electronic address: dwerb@ucsd.edu., Milloy MJ; Department of Medicine, University of British Columbia, V6T 1Z4 Vancouver, Canada; British Columbia Centre on Substance Use, V6Z 2A9 Vancouver, Canada. Electronic address: mj.milloy@bccsu.ubc.ca., Bonato S; Centre for Addiction and Mental Health, M5T 1R8 Toronto, Canada. Electronic address: sarah.bonato@camh.ca., Maghsoudi N; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, M5T 3M6 Toronto, Canada; Centre on Drug Policy Evaluation, St. Michael's Hospital, M5B 1W8 Toronto, Canada. Electronic address: nazlee.maghsoudi@mail.utoronto.ca., Rueda S; Institute for Mental Health Policy Research and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, M5T 1R8 Toronto, Canada; Department of Psychiatry, University of Toronto, M5T 1R8 Toronto, Canada; Institute of Medical Science, University of Toronto, M5S 1A8 Toronto, Canada. Electronic address: ruedagento@gmail.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Drug and alcohol dependence [Drug Alcohol Depend] 2022 Jul 01; Vol. 236, pp. 109463. Date of Electronic Publication: 2022 Apr 15. |
DOI: | 10.1016/j.drugalcdep.2022.109463 |
Abstrakt: | Background: We were engaged by policy stakeholders to undertake a scoping review of cannabis measurement instruments to inform the evaluation of cannabis legalization impacts. We identified instruments employed in population-based or clinical research to screen and assess cannabis use, including measurement properties. We also identified the content domains included in each instrument and gaps in the measurement of key priority areas as established by policy stakeholders. Methods: We followed PRISMA and conducted searches on MEDLINE, PsycINFO, Web of Science, EMBASE, HAPI, Scopus and grey literature. We included publications from the past 15 years that reported the use of an instrument to measure cannabis use. Six study team members calibrated screening and data abstraction, independently identified records and abstracted data. Results: Across 915 included publications, we identified 187 unique instruments covering seven content domains and 35 subdomains. The most identified instruments were the Composite International Diagnostic Interview, the Timeline Follow-Back and the National Epidemiologic Survey on Alcohol and Related Conditions (109/915; 91/915; 64/915). The Canadian Cannabis Survey addressed the most subdomains (22/35). Frequency of use, prevalence of use, and mental health impacts were the most addressed subdomains (110/187; 94/187; 67/187) and storage, growing cannabis, and second-hand exposure were the least addressed (1/187; 4/187; 6/187). Conclusion: This research identified instruments and domains critical to the assessment of public health impacts of cannabis legalization, which can facilitate the harmonization of measures to inform policy development. Future research should develop new instruments for less commonly-addressed constructs and thoroughly explore psychometric properties of existing instruments. (Copyright © 2022 Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |